address1,address2,city,zip,country,phone,fax,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,fiveYearAvgDividendYield,beta,trailingPE,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,shortName,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,regularMarketChangePercent,regularMarketPrice,marketState,longName,trailingPegRatio
Ajanta House,98 Govt. Industrial Area Charkop Kandivili (West),Mumbai,400067,India,91 22 6606 1000,91 22 6606 1200,https://www.ajantapharma.com,Drug Manufacturers - Specialty & Generic,drug-manufacturers-specialty-generic,Drug Manufacturers - Specialty & Generic,Healthcare,healthcare,Healthcare,"Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company, development, manufacturing and marketing of speciality pharmaceutical finished dosages. It also offers chronic, and acute therapies; and tablets, capsules, injectables, inhalers, ointments, creams and liquids. The company engages in molecule and therapeutic segments. The company serves in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.",9628,"[{'maxAge': 1, 'name': 'Mr. Yogesh Mannalal Agrawal M.B.A', 'age': 52, 'title': 'MD & Executive Director', 'yearBorn': 1972, 'fiscalYear': 2025, 'totalPay': 246441600, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Rajesh Mannalal Agrawal M.B.A', 'age': 48, 'title': 'Joint MD & Director', 'yearBorn': 1976, 'fiscalYear': 2025, 'totalPay': 246441600, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Madhusudan Bhagwandas Agrawal B.Sc', 'age': 69, 'title': 'Executive Vice Chairman of the Board', 'yearBorn': 1955, 'fiscalYear': 2025, 'totalPay': 48399600, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Arvind K. Agrawal B Com, F.C.A, L.L.B', 'age': 61, 'title': 'Chief Financial Officer', 'yearBorn': 1963, 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Gaurang Chinubhai Shah', 'title': 'Senior VP of Legal, VP of Corporate Affairs, Company Secretary & Compliance Officer', 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}]",1767139200,[],86400,2,2545.7,2545.0,2525.0,2594.9,2545.7,2545.0,2525.0,2594.9,54.0,2.12,1730851200,0.3808,0.81,0.243,35.1801,26.069702,88089,88089,119826,143999,143999,0.0,0.0,0,0,323297247232,2160.15,3485.0,6.955471,2597.888,2818.0227,28.0,0.010998939,INR,False,314310721536,0.19801001,42106101,124912000,0.65997005,0.21474001,126600000,301.586,8.581964,1743379200,1774915200,1743379200,0.111,9203900416,73.57,99.28,3:2,1655856000,6.762,25.1,0.08519304,0.094471335,28.0,1730851200,EQUITY,2588.2,3460.0,2288.0,2993.9167,3140.0,2.16667,buy,12,6138500096,48.843,12522399744,509200000,1.845,2.854,46480998400,1.343,371.471,0.14612001,0.25019,35052101632,6620612608,11572299776,0.121,0.11,0.75412005,0.26941,0.21921,INR,AJANTPHARM.NS,en-US,US,Equity,Delayed Quote,True,HIGH,AJANTA PHARMA LIMITED,[],1750413590,NSI,finmb_139957,Asia/Kolkata,IST,19800000,in_market,False,False,1025495100000,42.5,2525.0 - 2594.9,NSE,119826,428.05005,0.19815756,2160.15 - 3485.0,-896.80005,-0.25733143,8.519304,1746010740,1753700340,1754049600,1746010800,1746010800,True,73.57,99.28,84.62,30.58615,-9.687988,-0.0037291786,-229.82275,-0.081554614,15,15,2.2 - Buy,False,1.669482,2588.2,POSTPOST,Ajanta Pharma Limited,
